Prevalence and comorbidities of chronic hepatitis C: a nationwide population-based register study in Sweden

References

• Wilder JM, Muir AJ. Strategies for treating chronic HCV infection in patients with cirrhosis: latest evidence and clinical outcomes. Ther Adv Chronic Dis. 2015;6:314–327.
   PubMed Web of Science ®Google Scholar
• Mohd Hanafiah K, Groeger J, Flaxman AD, et al. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology (Baltimore, MD). 2013;57:1333–1342.
   PubMed Web of Science ®Google Scholar
• Duberg AS, Pettersson H, Aleman S, et al. The burden of hepatitis C in Sweden: a national study of inpatient care. J Viral Hepatitis. 2011;18:106–118.
   PubMed Web of Science ®Google Scholar
• Duberg AS, Blach S, Falconer K, et al. The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies. Scand J Gastroenterol. 2015;50:233–244.
   PubMed Web of Science ®Google Scholar
• Bruggmann P, Berg T, Ovrehus AL, et al. Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepatitis. 2014;21:5–33.
   PubMed Web of Science ®Google Scholar
• Gordis L. Epidemiology. 3rd ed. Philadelphia, PA: Elsevier Inc.; 2004.
   Google Scholar
• Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.
   PubMed Web of Science ®Google Scholar
• Barlow L, Westergren K, Holmberg L, et al. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncologica (Stockholm, Sweden). 2009;48:27–33.
   PubMed Web of Science ®Google Scholar
• National Board of Health and Welfare. Cancer Incidence in Sweden 2011. Official Statistics of Sweden. Health and Diseases 2012.
   Google Scholar
• Wettermark B, Hammar N, Fored CM, et al. The new Swedish Prescribed Drug Register–opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Safety. 2007;16:726–735.
   PubMed Web of Science ®Google Scholar
• Statistics Sweden. To measure and monitor internal migration based on national population register. Publications in the series Background facts on Population and Welfare Statistics. 2006.
   Google Scholar
• WHO. Collaborating Centre for Drug Statistics Methodology. ATC index. Available from: http://www.whoccno/atc_ddd_index/.
   Google Scholar
• Nordic Medico-Statistical Committee (NOMESCO). Classification of Surgical Procedures (NCSP), Version 1.6, Copenhagen: Nordic Centre for Classifications in Health Care; 2002.
   Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.
   PubMedGoogle Scholar
• Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Medical Care. 2005;43:1130–1139.
   PubMed Web of Science ®Google Scholar
• Socialstyrelsen. Klassifikation av sjukdomar – 1987, Swedish Version of the International Classification of Diseases, Ninth Revision (ICD-9). Stockholm: Swedish National Board on Health and Welfare; 1987.
   Google Scholar
• Socialstyrelsen. Internationell statistisk klassifikation av sjukdomar och relaterade h€alsoproblem, Swedish version of the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10). Stockholm: Swedish National Board on Health and Welfare; 2011.
   Google Scholar
• Chen SLMT. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci. 2006;3:47–52.
   PubMedGoogle Scholar
• Hoffmann G, Berglund G, Elmstahl S, et al. Prevalence and clinical spectrum of chronic viral hepatitis in a middle-aged Swedish general urban population. Scand J Gastroenterol. 2000;35:861–865.
   PubMed Web of Science ®Google Scholar
• Cornberg M, Razavi HA, Alberti A, et al. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver Int. 2011;31:30–60.
   PubMed Web of Science ®Google Scholar
• Lagging M, Romero AI, Westin J, et al. IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection. Hepatology (Baltimore, MD). 2006;44:1617–1625.
   PubMed Web of Science ®Google Scholar
• Romero AI, Lagging M, Westin J, et al. Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection. J Infect Dis. 2006;194:895–903.
   PubMed Web of Science ®Google Scholar
• Askarieh G, Alsio A, Pugnale P, et al. Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C. Hepatology (Baltimore, MD). 2010;51:1523–1530.
   PubMed Web of Science ®Google Scholar
• Zampino R, Marrone A, Restivo L, et al. Chronic HCV infection and inflammation: clinical impact on hepatic and extra-hepatic manifestations. World J Hepatol. 2013;5:528–540.
   PubMedGoogle Scholar
• Ashrafi M, Modabbernia A, Dalir M, et al. Predictors of mental and physical health in non-cirrhotic patients with viral hepatitis: a case control study. J Psychosom Res. 2012;73:218–224.
   PubMed Web of Science ®Google Scholar
• Goh LY, Card T, Fogarty AW, et al. The association of exposure to hepatitis B and C viruses with lung function and respiratory disease: a population based study from the NHANES III database. Respir Med. 2014;108:1733–1740.
   PubMed Web of Science ®Google Scholar
• Allison RD, Tong X, Moorman AC, et al. Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006-2010. J Hepatol. 2015;63:822–828.
   PubMed Web of Science ®Google Scholar
• Büsch K, Ludvigsson JF, Ekstrom-Smedby K, Ekbom A, Askling J, Neovius M. Nationwide prevalence of inflammatory bowel disease in Sweden: a population-based register study. Alimentary pharmacology & therapeutics. 2014;39:57–68.
   PubMed Web of Science ®Google Scholar